Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD of AZD1722 With/Without Food and Omeprazole in Healthy Subjects
NCT02226783Phase 1Completed
- Sponsor
- Ardelyx
- Start
- Mar 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tenapanor in irritable bowel syndrome (IBS) and hyperphosphatemia (5 arms), sponsored by Ardelyx. Primary endpoint: Pharmacodynamics (Stool). Started Mar 2013; status: completed.
02
Drugs
tenapanor
03
Conditions
irritable bowel syndrome (IBS)hyperphosphatemia
Beyond the preview
Go deeper on NCT02226783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02226783.